From Beat to Risk: How Heart Rate Variability Predicts Arrhythmias in Type 2 Diabetes.

Area of Science:

• Cardiology
• Endocrinology
• Autonomic Neuroscience

Background:

• Type 2 diabetes mellitus (T2DM) significantly elevates cardiovascular complication risks, notably cardiac autonomic neuropathy (CAN).
• CAN results in sympathetic-parasympathetic imbalance, increasing arrhythmia and sudden cardiac death susceptibility.
• Heart rate variability (HRV) serves as a non-invasive marker for autonomic dysfunction and arrhythmogenic risk.

Purpose of the Study:

• To investigate the role of HRV in assessing autonomic dysfunction in T2DM patients.
• To explore the correlation between HRV parameters and cardiovascular risk in T2DM.
• To evaluate the clinical utility of HRV analysis for early detection and management of CAN.

Main Methods:

• Utilized R-R interval data from electrocardiography and 24-hour Holter monitoring for HRV assessment.
• Analyzed conventional time- and frequency-domain HRV indices (SDNN, RMSSD, pNN50, total power, high-frequency component).
• Incorporated nonlinear HRV indices to assess complexity and fractal organization.

Main Results:

• Patients with T2DM exhibited reduced HRV indices, indicating diminished parasympathetic tone and sympathetic predominance.
• Chronic hyperglycemia, oxidative stress, and metabolic inflammation contribute to early autonomic nervous system impairment.
• Reduced HRV correlated with CAN severity, diabetes duration, and poor glycemic control, highlighting increased arrhythmogenic vulnerability.

Conclusions:

• HRV analysis is a valuable tool for predicting arrhythmic risk in T2DM patients.
• Reduced HRV signifies increased susceptibility to cardiovascular events and sudden cardiac death.
• Integrating HRV assessment into clinical practice can optimize cardiovascular risk stratification and management in T2DM.